Bharat Immunological & Biological Corporation standalone net profit rises 325.00% in the March 2017 quarter

Sales rise 3.98% to Rs 61.34 crore

Net profit of Bharat Immunological & Biological Corporation rose 325.00% to Rs 4.08 crore in the quarter ended March 2017 as against Rs 0.96 crore during the previous quarter ended March 2016. Sales rose 3.98% to Rs 61.34 crore in the quarter ended March 2017 as against Rs 58.99 crore during the previous quarter ended March 2016.

For the full year,net profit reported to Rs 6.68 crore in the year ended March 2017 as against net loss of Rs 6.21 crore during the previous year ended March 2016. Sales declined 3.00% to Rs 124.19 crore in the year ended March 2017 as against Rs 128.03 crore during the previous year ended March 2016.

ParticularsQuarter EndedYear EndedMar. 2017Mar. 2016% Var.Mar. 2017Mar. 2016% Var.Sales61.3458.99 4 124.19128.03 -3 OPM %11.172.90 -8.99-5.69 - PBDT6.001.21 396 9.81-8.31 LP PBT5.991.43 319 9.50-8.96 LP NP4.080.96 325 6.68-6.21 LP

Powered by Capital Market - Live News